Quercetin handles cellular oxidant/antioxidant systems and mitigates immunosenescence hallmarks in human PBMCs: An in vitro study
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Samia Bouamama und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory of Specialized Hospital Center (EHS)-Ain Temouchent, Ain Temouchent, Algeria. Hauptthemen laut MEDLINE: Antioxidants, Immunosenescence. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Direction Générale de la Recherche Scientifique et du Développement Technologique.
Abstract (Originalsprache)
Immunosenescence, oxidative stress, and low vaccine efficacy are important symptoms of aging. The goal of our study was to test if quercetin had antiaging and stimulating effects on peripheral blood mononuclear cell (PBMC) immune cells in vitro in the presence of concanavalin a, PBMCs were isolated from healthy elderly and young people and cultured in a complete Roswell Park Memorial Institute 1640 medium supplemented with quercetin. Cell proliferation was assessed using the 3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2H‐tetrazolium bromide colorimetric assay after a 48‐h incubation period. Spectrophotometric assays were used to assess oxidative biomarkers (proteins carbonyl [PC], malondialdehydes [MDA], and reduced glutathione [GSH]). The enzyme‐linked immunosorbent assay method was used to determine the amount of interleukin (IL)‐2 released. A Griess reagent was used to investigate inducible nitrite oxide synthase ( i NOS) activity. When compared to young control cells, aged PBMCs had lower proliferation potency, lower IL‐2 and NO release, and higher MDA and PC levels. Importantly, quercetin‐treated aged PBMCs have a high proliferative response comparable to young cells, restored i NOS activity, and increased levels of GSH antioxidant defences. In comparison to untreated aged PBMCs, treated PBMCs have lower lipo‐oxidative damage but higher PC levels. Quercetin may be used as a promising dietary vaccinal adjuvant in the elderly, it has significant effects in reducing immunosenescence hallmarks, as well as mitigating the lipo‐oxidative stress in PBMCs cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Laboratory of Specialized Hospital Center (EHS)-Ain Temouchent, Ain Temouchent, Algeria.
- Department of Biology, Faculty of Naturaland Life Sciences, Earth and Universe, Abou Bekr Belkaid University, Tlemcen, Algeria.
- Department of Foreign Languages, Literatures and Languages Faculty, Abou Bekr Belkaid University, Tlemcen, Algeria.
Förderung
- Direction Générale de la Recherche Scientifique et du Développement Technologique
Zitieren
APA
Bouamama, S., & Bouamama, A. (2023). Quercetin handles cellular oxidant/antioxidant systems and mitigates immunosenescence hallmarks in human PBMCs: An in vitro study. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23354
Vancouver
Bouamama S, Bouamama A. Quercetin handles cellular oxidant/antioxidant systems and mitigates immunosenescence hallmarks in human PBMCs: An in vitro study. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23354
BibTeX
@article{Bouamama2023,
author = {Bouamama, Samia and Bouamama, Amina},
title = {Quercetin handles cellular oxidant/antioxidant systems and mitigates immunosenescence hallmarks in human PBMCs: An in vitro study},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23354}
}
EUVIMED